Ironwood Pharmaceuticals Current Cash

Ironwood Pharmaceuticals (IRWD) currently reports a current cash of $79M as of June 2026. That compares with $93M in the prior-year period — down 14.8% year over year. Use the charts on this page to explore Ironwood Pharmaceuticals's current cash history and peer comparisons.

Ironwood Pharmaceuticals's current cash decreased from $93M to $79M — a 14.8% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Ironwood Pharmaceuticals reported $79M in current cash as of June 2026. That compares with $93M in the prior-year period — down 14.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $79M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Ironwood Pharmaceuticals, and consider following IRWD for alerts when major investors trade the stock.

Ironwood Pharmaceuticals is classified in the Healthcare sector. On current cash, it currently shows $79M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing IRWD with unrelated industries.